Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.
Also called NCT01975818
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 201 participants
- Sponsor
- Registry
-
NCT01975818
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Japan
- Registry status
- Completed
Technical summary
Registry record NCT01975818. Randomized; no masking; primary purpose treatment. Start 2013-10-28 (actual); primary completion 2015-10-23 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
- Acronym
- DIALOGUE4
- Condition
- Anemia
- Condition
- Renal Insufficiency, Chronic
- Intervention (Drug)
- Molidustat (BAY 85-3934)
- Intervention (Biological)
- Epoetin alfa/beta
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct01975818- Content hash
1e5a2f77e0a593f5f060e6937f35e36e887cc5f4d7cb3c13ad3b447c7d7c7355